Stocktoria
Replimune Group, Inc. REPL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-07-20
Replimune Group, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 4,713,791 | $42.4M |
| D. E. Shaw & Co., Inc. | 2,336,528 | $17.9M |
| CITADEL ADVISORS LLC | 823,829 | $6.3M |
| MILLENNIUM MANAGEMENT LLC | 483,433 | $3.7M |
| RENAISSANCE TECHNOLOGIES LLC | 381,453 | $2.9M |
| TWO SIGMA INVESTMENTS, LP | 344,751 | $2.6M |
| AQR CAPITAL MANAGEMENT LLC | 255,495 | $2.0M |
Source: SEC EDGAR filings · CIK 0001737953 · as of 2025-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.